Geopolitics & Trade

The French biopharma giant posts strong 2025 results and forecasts over 13% growth, fueled by a booming pipeline and unexpected market advantages.

A potential first therapy for Charcot-Marie-Tooth disease heads to a major conference, showing promising functional gains despite missing its primary goal.

Estonian lender Bigbank AS taps private investors for a €3 million AT1 bond issuance, a strategic move to bolster its capital base amid ambitious growth plans.

A new report shows 40% of ANZ firms never assess skin cancer risk, despite 84% seeing it as a duty of care, exposing a massive legal and health liability.

Gabelli Multimedia Trust maintains its high-yield distribution after a blockbuster 2025, but what does its 21% 'cash on cash' payout really mean for investors?

The insurer's double-digit dividend hike follows a year of record core earnings, rewarding shareholders and showcasing its robust financial health.

The satellite firm unveils a complex debt shuffle and $1B capital raise, fueling its network vision while sending its stock tumbling on dilution fears.

As a Fed study confirms the 'harvest now, decrypt later' threat is active, Dr. Joseph Kearney joins QRL to spearhead a quantum-safe future for blockchain.

With 6,000+ attendees, INTA's London meeting will tackle AI inventorship, global brand protection, and the future of innovation. Here's what's at stake.

Dating apps are out, and home cooking is in. A new campaign from Knorr taps into Gen Z's search for authenticity, turning kitchens into the new frontier for romance.

Data engine Cribl surpasses $300M in recurring revenue, positioning its open architecture as the essential plumbing for enterprises drowning in AI data.

The retail REIT's latest dividend declaration reflects a trend of growing shareholder returns, signaling strategic stability in a shifting market.

The health tech firm posts strong revenue and positive EBITDA, but SEC filings and a falling stock price reveal a more complex and challenging road ahead.

NXP expands its use of Arteris's specialized IP, a strategic move to accelerate its dominance in the competitive automotive and industrial edge AI markets.

The nation's largest private bank is expanding its Oklahoma City campus, acquiring a former energy building in a move that signals local faith and national ambition.

A bipartisan federal investigation will scrutinize university and government responses to a historic surge in antisemitism on college campuses since Oct. 7.

The Virginia bank replaced costly floating-rate debt with a fixed-rate offering, signaling strong investor confidence and fortifying its capital base.

Vynleads launches its Done With Diabetes app, using AI for daily support. But can it stand out in a crowded market and reverse its financial fortunes?

With a new hospital's opening at stake, Vaudreuil-Soulanges leaders demand special immigration powers to avert a looming economic and healthcare crisis.

The Investment Company Institute is linking its industry to America's 250th birthday. Is it a genuine celebration or a strategic rebrand?